Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project.

1. Flint AJ. Epidemiology and comorbidity of the anxiety disorders in the elderly. Am J Psychiatry 1994; 151: 640–9. 2. Sheikh JI. Anxiety disorders and their treatment. Clin Geriatr Med 1992; 8: 411–26. 3. Tucker GJ. Treatment approaches to anxiety, depression and aggression in the elderly. J Clin Psychiatry 1994;; 55(Suppl.): 3–4. 4. Weiss KJ. Management of anxiety and depression syndromes in the elderly. J Clin Psychiatry 1994; 55(Suppl.): 5–12. 5. Barlow DH, Campbell LA. Mixed anxiety-depression and its implications for models of mood and anxiety disorders. Compr Psychiatry 2000; 41: 55–60. 6. Mehta KM, Simonsick EM, Penninx BW et al. Prevalence and correlates of anxiety symptoms in well-functioning older adults: findings from the health aging and body composition study. J Am Geriatr Soc 2003; 51: 499–504. 7. Mackinnon A, Christensen H, Form A et al. A latent trait analysis of an inventory designed to detect symptoms of anxiety and depression using an elderly community sample. Psychol Med 1994; 24: 977–86. 8. Christensen H, Jorm AF, Mackinnon AJ et al. Age differences in depression and anxiety symptoms: a structural equation modelling analysis of data from a general population sample. Psychol Med 1999; 29: 325–39. 9. Goldberg D, Bridges K, Duncan-Jones P et al. Dimensions of neuroses seen in primary-care settings. Psychol Med 1987; 17: 461–70. 10. Goldberg D, Bridges K, Duncan-Jones P et al. Detecting anxiety and depression in general medical settings. Br Med J 1988; 297: 897–9. 11. Schoevers RA, Beekman AT, Deeg DJ et al. Comorbidity and risk-patterns of depression, generalised anxiety disorder and mixed anxiety-depression in later life: results from the AMSTEL study. Int J Geriatr Psychiatry 2003; 18: 994–1001. 12. Copeland JRM, Dewey ME, Griffiths-Jones HM. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med 1986; 16: 89–99. 13. Brown WJ, Bryson L, Byles J et al. Women’s Health Australia: recruitment for a national longitudinal cohort study. Women Health 1998; 28: 23–40. 14. Lee C, Dobson AJ, Brown WJ et al. Cohort profile: The Australian Longitudinal Study on Women’s Health. Int J Epidemiol 2005; 34: 987–91. 15. McCallum J. The SF-36 in an Australian sample: Validating a new generic health status measure. Aust J Public Health 1995; 9: 160–6. 16. Ware JE Jr, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scores: A User’s Manual. Boston, MA: The Health Institute, 1994. 17. Holmes WC. A short, psychiatric, case finding measure for HIV seropositive outpatients: performance characteristics of the 5-item mental health subscale of the SF-20 in a male, seropositive sample. Med Care 1998; 36: 237–43. 18. Fraser C, McDonald RP. NOHARM: least squares item factor analysis. Multivariate Behav Res 1988; 23: 267–9. 19. Finch H. Comparison of the performance of varimax and promax rotations: factor structure recovery for dichotomous items. J Educ Meas 2006; 43: 39. 20. Clarke D, Mackinnon A, Smith G et al. Dimensions of psychopathology in the medically ill: a latent trait analysis. Psychosomatics 2000; 41: 48–425.